AlphaMadera's AlphaVal page classifies Kennedy-Wilson Holdings, Inc. as a Stable Earnings Power business and values it using P/Adj-EPS × Normalized Multiple, then compares the result to the current market price to flag KW as undervalued, fairly valued, or overvalued.

What is Kennedy-Wilson Holdings, Inc.'s fair value?

Fair value for KW comes from a P/Adj-EPS × Normalized Multiple model -- the approach AlphaVal selected for this company's Stable Earnings Power classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value KW?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. KW was classified as Stable Earnings Power and is valued using P/Adj-EPS × Normalized Multiple, built from KW's most recent reported fundamentals.

KW - Kennedy-Wilson Holdings, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 60% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong

Trading 67.0% above fair value

Current Price $10.92

Bear Case $5.23 52.1% downside ($5.23 - $10.92) / $10.92 = -52.1% $0.44 × 12x P/E

Fair Value $6.54 40.1% downside ($6.54 - $10.92) / $10.92 = -40.1% $0.44 × 15x P/E

Bull Case $7.85 28.1% downside ($7.85 - $10.92) / $10.92 = -28.1% $0.44 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

0.44$

Key Value Driver

Normalized P/E multiple (15x base case)

Terminal Value % of EV

Implied Market Multiple 25.0x

Market is pricing in (growth)

Plain-Language Summary

Applying a 15x P/E to adjusted EPS of $0.44, the base-case value is $6.54 per share.

Warnings

⚠ The company's reported profits differ from official accounting profits by 1353%. Check what costs are being left out of the adjusted number.

⚠ The company pays out 1600% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples